BioChem to distribute Saliva Diagnostic tests:
This article was originally published in Clinica
BioChem ImmunoSystems is to distribute Saliva Diagnostic Systems' rapid HIV test components under a three-year private label agreement worldwide except for India and Israel. Canadian company BioChem will be responsible for local registration. The deal also gives US company Saliva Diagnostic access to patented raw materials, which will facilitate manufacture and distribution of new and existing kits.